Trials / Completed
CompletedNCT06692647
A Clinical Study of MK-4318 and Diltiazem in Healthy People (MK-4318-003)
A Two-period Study to Evaluate the Effects of Multiple Oral Doses of Diltiazem on the Single-dose Pharmacokinetics of MK-4318 in Healthy Participants
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 19 (actual)
- Sponsor
- Merck Sharp & Dohme LLC · Industry
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The goal of this study is to learn what happens to MK-4318 in a person's body over time. Researchers will compare what happens to levels of MK-4318 in people's blood when it is taken with and without diltiazem. Researchers also want to learn about the safety of MK-4318 taken with and without diltiazem and if people tolerate them.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | MK-4318 | Oral administration |
| DRUG | Diltiazem | Oral administration |
Timeline
- Start date
- 2024-02-09
- Primary completion
- 2024-04-11
- Completion
- 2024-04-11
- First posted
- 2024-11-18
- Last updated
- 2024-11-18
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT06692647. Inclusion in this directory is not an endorsement.